边缘区淋巴瘤临床试验设计的路线图。
A roadmap for clinical trial design in marginal zone lymphoma.
机构信息
Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA.
Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
出版信息
Am J Hematol. 2022 Nov;97(11):1398-1403. doi: 10.1002/ajh.26706. Epub 2022 Sep 12.
Abstract
Marginal zone lymphoma (MZL) is commonly underrepresented in clinical trials collectively studying mostly nodal indolent lymphomas.In this manuscript we propose new inclusion and response criteria defined by MZL subtype and disease location for those with extranodal MZL. Progression of disease within 24 months is associated with poor outcomes in MZL and future studies should assess the efficacy of novel agents in this population.
摘要
边缘区淋巴瘤（MZL）在共同研究大多数结内惰性淋巴瘤的临床试验中通常代表性不足。在本研究中，我们提出了新的纳入和缓解标准，根据结外 MZL 的 MZL 亚型和疾病部位进行定义。24 个月内疾病进展与 MZL 的不良预后相关，未来的研究应评估新型药物在该人群中的疗效。
相似文献
1
A roadmap for clinical trial design in marginal zone lymphoma.边缘区淋巴瘤临床试验设计的路线图。
Am J Hematol. 2022 Nov;97(11):1398-1403. doi: 10.1002/ajh.26706. Epub 2022 Sep 12.
2
Management of Marginal Zone Lymphoma: A Canadian Perspective.边缘区淋巴瘤的治疗：加拿大的观点。
Curr Oncol. 2023 Feb 1;30(2):1745-1759. doi: 10.3390/curroncol30020135.
3
Front-line management of indolent non-Hodgkin lymphoma in Australia. Part 2: mantle cell lymphoma and marginal zone lymphoma.澳大利亚惰性非霍奇金淋巴瘤的一线治疗。第 2 部分：套细胞淋巴瘤和边缘区淋巴瘤。
Intern Med J. 2019 Sep;49(9):1070-1080. doi: 10.1111/imj.14268.
4
A phase II study of the PI3K inhibitor copanlisib in combination with the anti-CD20 monoclonal antibody rituximab for patients with marginal zone lymphoma: treatment rationale and protocol design of the COUP-1 trial.一项评估 PI3K 抑制剂 copanlisib 联合抗 CD20 单克隆抗体利妥昔单抗治疗边缘区淋巴瘤患者的 II 期研究：COUP-1 试验的治疗原理和方案设计。
BMC Cancer. 2021 Jun 29;21(1):749. doi: 10.1186/s12885-021-08464-6.
5
Marginal Zone Lymphoma: Clinicopathologic Variations and Approaches to Therapy.边缘区淋巴瘤：临床病理变异与治疗方法。
Curr Oncol Rep. 2018 Mar 23;20(4):33. doi: 10.1007/s11912-018-0687-9.
6
Marginal Zone Lymphoma: State-of-the-Art Treatment.边缘区淋巴瘤：最新治疗方法。
Curr Treat Options Oncol. 2019 Dec 5;20(12):90. doi: 10.1007/s11864-019-0687-5.
7
Primary nodal marginal zone lymphomas of splenic and MALT type.脾脏和MALT型原发性淋巴结边缘区淋巴瘤。
Am J Surg Pathol. 1999 Jan;23(1):59-68. doi: 10.1097/00000478-199901000-00006.
8
Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.边缘区B细胞淋巴瘤：淋巴结型与黏膜相关淋巴组织型的临床比较。非霍奇金淋巴瘤分类项目。
J Clin Oncol. 1999 Aug;17(8):2486-92. doi: 10.1200/JCO.1999.17.8.2486.
9
Marginal zone B-cell lymphomas.边缘区B细胞淋巴瘤
Discov Med. 2010 Jul;10(50):79-86.
10
Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma.髓系细胞核分化抗原在边缘区淋巴瘤的一个亚群中表达，对于与滤泡性淋巴瘤的鉴别诊断很有用。
Hum Pathol. 2014 Aug;45(8):1730-6. doi: 10.1016/j.humpath.2014.04.004. Epub 2014 Apr 24.
引用本文的文献
1
Retrospective analysis of primary pulmonary lymphoma cases from Polish Lymphoma Research Group centers reveals associations between initial symptoms and outcomes.波兰淋巴瘤研究小组中心对原发性肺淋巴瘤病例的回顾性分析揭示了初始症状与预后之间的关联。
Sci Rep. 2025 Jul 30;15(1):27883. doi: 10.1038/s41598-025-12469-7.
2
SOHO State of the Art Updates and Next Questions | Current and Emerging Novel Treatments for Marginal Zone Lymphoma.SOHO最新技术进展与后续问题 | 边缘区淋巴瘤的当前及新出现的新型治疗方法
Clin Lymphoma Myeloma Leuk. 2025 May 31. doi: 10.1016/j.clml.2025.05.021.
3
PET/CT in the Staging and Treatment Response Assessment of Patients With Extranodal Marginal Zone Lymphoma.正电子发射断层扫描/计算机断层扫描在结外边缘区淋巴瘤患者分期及治疗反应评估中的应用
Am J Hematol. 2025 Aug;100(8):1295-1304. doi: 10.1002/ajh.27712. Epub 2025 May 21.
4
Enhancing prognostication and personalizing treatment of extranodal marginal zone lymphoma.提高结外边缘区淋巴瘤的预后预测和实现个体化治疗。
Expert Rev Hematol. 2023 May;16(5):333-348. doi: 10.1080/17474086.2023.2206557. Epub 2023 Apr 28.
本文引用的文献
1
The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways.眼附属器黏膜相关淋巴组织淋巴瘤的遗传学特征揭示了 NFAT 和 MEF2B 信号通路的频繁异常。
Cancer Res Commun. 2021 Oct;1(1):1-16. doi: 10.1158/2767-9764.crc-21-0022. Epub 2021 Oct 13.
2
Systematic review reveals urgent need to homogenize endpoints choices and definitions in marginal zone lymphomas trials.系统评价揭示了在边缘区淋巴瘤试验中统一终点选择和定义的迫切需求。
Leuk Lymphoma. 2022 Jul;63(7):1544-1555. doi: 10.1080/10428194.2022.2032038. Epub 2022 Feb 24.
3
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma.一项评估苯达莫司汀联合利妥昔单抗治疗结外边缘区淋巴瘤的国际分析。
Blood Adv. 2022 Apr 12;6(7):2035-2044. doi: 10.1182/bloodadvances.2021006844.
4
Marginal-Zone Lymphomas.边缘区淋巴瘤
N Engl J Med. 2022 Feb 10;386(6):568-581. doi: 10.1056/NEJMra2102568.
5
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study.奥妥珠单抗联合来那度胺治疗晚期、既往未治疗且需要全身治疗的滤泡性淋巴瘤：一项LYSA研究。
Blood. 2022 Apr 14;139(15):2338-2346. doi: 10.1182/blood.2021013526.
6
Genetic and phenotypic attributes of splenic marginal zone lymphoma.脾脏边缘区淋巴瘤的遗传和表型特征。
Blood. 2022 Feb 3;139(5):732-747. doi: 10.1182/blood.2021012386.
7
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial.Copanlisib 联合利妥昔单抗与安慰剂联合利妥昔单抗治疗复发惰性非霍奇金淋巴瘤（CHRONOS-3）：一项双盲、随机、安慰剂对照、3 期临床试验。
Lancet Oncol. 2021 May;22(5):678-689. doi: 10.1016/S1470-2045(21)00145-5. Epub 2021 Apr 10.
8
Epidemiology of Marginal Zone Lymphoma.边缘区淋巴瘤的流行病学
Ann Lymphoma. 2021 Mar;5. doi: 10.21037/aol-20-28. Epub 2021 Mar 30.
9
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma.乌布雷昔布，一种用于复发性或难治性惰性淋巴瘤患者的双重 PI3Kδ/CK1ε 抑制剂。
J Clin Oncol. 2021 May 20;39(15):1609-1618. doi: 10.1200/JCO.20.03433. Epub 2021 Mar 8.
10
Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis.复发/难治性边缘区淋巴瘤中依鲁替尼的持久反应：长期随访和生物标志物分析
Blood Adv. 2020 Nov 24;4(22):5773-5784. doi: 10.1182/bloodadvances.2020003121.
Zotero 插件